BioGredient II ApS: Financial statements 2020
CVR: 37759724
Source: annual report 2020, Danish Business Authority
01/07/2019 – 30/06/2020
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 0.
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 0 | 0 | - |
| 2019 | - | 0 | 0 | 0 | - |
| 2018 | - | - | -40 t. | 0 | - |
| 2017 | - | - | -10 t. | 40 t. | - |
Official annual report
How creditworthy is BioGredient II ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BioGredient II ApS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK 0.
About BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is in liquidation. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The management consists of Anders Hoffmann Kønigsfeldt. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.